[1] Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE. Cerebral small vessel disease:from a focal to a global perspective[J]. Nat Rev Neurol, 2018, 14:387-398.
[2] Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease:a clinical review[J]. Neurology, 2019, 92:1146-1156.
[3] Wardlaw JM, Smith C, Dichgans M. Small vessel disease:mechanisms and clinical implications[J]. Lancet Neurol, 2019, 18:684-696.
[4] de Heus RAA, Reumers SFI, van der Have A, Tumelaire M, Tully PJ, Claassen JAHR. Day-to-day home blood pressure variability is associated with cerebral small vessel disease burden in a memory clinic population[J]. J Alzheimers Dis, 2020, 74:463-472.
[5] Tully PJ, Yano Y, Launer LJ, Kario K, Nagai M, Mooijaart SP, Claassen JAHR, Lattanzi S, Vincent AD, Tzourio C; the Variability in Blood Pressure and Brain Health Consortium. Association between blood pressure variability and cerebral small-vessel disease:a systematic review and Meta-analysis[J]. J Am Heart Assoc, 2020, 9:e013841.
[6] Filomena J, Riba-Llena I, Vinyoles E, Tovar JL, Mundet X, Castañé X, Vilar A, López-Rueda A, Jiménez-Baladó J, Cartanyà A, Montaner J, Delgado P; ISSYS Investigators. Short-term blood pressure variability relates to the presence of subclinical brain small vessel disease in primary hypertension[J]. Hypertension, 2015, 66:634-640.
[7] Yang S, Qin W, Yang L, Fan H, Li Y, Yin J, Hu W. The relationship between ambulatory blood pressure variability and enlarged perivascular spaces:a cross-sectional study[J]. BMJ Open, 2017, 7:e015719.
[8] Liu W, Liu R, Sun W, Peng Q, Zhang W, Xu E, Cheng Y, Ding M, Li Y, Hong Z, Wu J, Zeng J, Yao C, Huang Y; CASISP Study Group. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions[J]. Stroke, 2012, 43:2916-2922.
[9] Palatini P. Day-by-day blood pressure variability:cause or consequence of vascular brain injury[J]? Hypertension, 2014, 63:1163-1165.
[10] Liu N, Xue Y, Tang J, Zhang M, Ren X, Fu J. The dynamic change of phenotypic markers of smooth muscle cells in an animal model of cerebral small vessel disease[J]. Microvasc Res, 2021, 133:104061.
[11] Tang J, Xiao W, Li Q, Deng Q, Chu X, Chen Y, Pan D, Fu J. A cyclooxygenase-2 inhibitor reduces vascular wall thickness and ameliorates cognitive impairment in a cerebral small vessel diseases rat model[J]. Curr Alzheimer Res, 2015, 12:704-710.
[12] Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature:implications for end-organ damage[J]. J Appl Physiol (1985), 2008, 105:1652-1660.
[13] Jolly TA, Bateman GA, Levi CR, Parsons MW, Michie PT, Karayanidis F. Early detection of microstructural white matter changes associated with arterial pulsatility[J]. Front Hum Neurosci, 2013, 7:782.
[14] Zhang K, Jiang Y, Wang Y, Suo C, Xu K, Zhu Z, Zhu C, Zhao G, Jin L, Ye W, Cui M, Chen X. Associations of arterial stiffness and carotid atherosclerosis with cerebral small vessel disease in a rural community-based population[J]. J Atheroscler Thromb, 2020, 27:922-933.
[15] Mok V, Ding D, Fu J, Xiong Y, Chu WW, Wang D, Abrigo JM, Yang J, Wong A, Zhao Q, Guo Q, Hong Z, Wong KS. Transcranial doppler ultrasound for screening cerebral small vessel disease:a community study[J]. Stroke, 2012, 43:2791-2793.
[16] Nam KW, Kwon HM, Lee YS. Distinct association between cerebral arterial pulsatility and subtypes of cerebral small vessel disease[J]. PLoS One, 2020, 15:e0236049.
[17] Lee KJ, Jung KH, Park CY, Kim JM, Lee ST, Chu K, Kim M, Lee SK, Roh JK. Increased arterial pulsatility and progression of single subcortical infarction[J]. Eur Radiol, 2017, 27:899-906.
[18] Chou KH, Wang PN, Peng LN, Liu LK, Lee WJ, Chen LK, Lin CP, Chung CP. Location-specific association between cerebral microbleeds and arterial pulsatility[J]. Front Neurol, 2019, 10:1012.
[19] Rosano C, Watson N, Chang Y, Newman AB, Aizenstein HJ, Du Y, Venkatraman V, Harris TB, Barinas-Mitchell E, Sutton-Tyrrell K. Aortic pulse wave velocity predicts focal white matter hyperintensities in a biracial cohort of older adults[J]. Hypertension, 2013, 61:160-165.
[20] Shi Y, Thrippleton MJ, Blair GW, Dickie DA, Marshall I, Hamilton I, Doubal FN, Chappell F, Wardlaw JM. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow[J]. J Cereb Blood Flow Metab, 2020, 40:85-99.
[21] Birnefeld J, Wåhlin A, Eklund A, Malm J. Cerebral arterial pulsatility is associated with features of small vessel disease in patients with acute stroke and TIA:a 4D flow MRI study[J]. J Neurol, 2020, 267:721-730.
[22] Schnerr RS, Jansen JFA, Uludag K, Hofman PAM, Wildberger JE, van Oostenbrugge RJ, Backes WH. Pulsatility of lenticulostriate arteries assessed by 7 Tesla Flow MRI-measurement, reproducibility, and applicability to aging effect[J]. Front Physiol, 2017, 8:961.
[23] Geurts LJ, Zwanenburg JJM, Klijn CJM, Luijten PR, Biessels GJ. Higher pulsatility in cerebral perforating arteries in patients with small vessel disease related stroke, a 7T MRI study[J]. Stroke, 2018, 50:STROKEAHA118022516.
[24] Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM. Cerebral blood flow in small vessel disease:a systematic review and meta-analysis[J]. J Cereb Blood Flow Metab, 2016, 36:1653-1667.
[25] Mochizuki Y, Oishi M, Takasu T. Cerebral blood flow in single and multiple lacunar infarctions[J]. Stroke, 1997, 28:1458-1460.
[26] Wang H, Nie ZY, Liu M, Li RR, Huang LH, Lu Z, Jin LJ, Li YX. Clinical characteristics of perivascular space and brain CT perfusion in stroke-free patients with intracranial and extracranial atherosclerosis of different extents[J]. Ann Transl Med, 2020, 8:215.
[27] Gregg NM, Kim AE, Gurol ME, Lopez OL, Aizenstein HJ, Price JC, Mathis CA, James JA, Snitz BE, Cohen AD, Kamboh MI, Minhas D, Weissfeld LA, Tamburo EL, Klunk WE. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals[J]. JAMA Neurol, 2015, 72:1021-1028.
[28] Yu C, Lu W, Qiu J, Wang F, Li J, Wang L. Alterations of the whole cerebral blood flow in patients with different total cerebral small vessel disease burden[J]. Front Aging Neurosci, 2020, 12:175.
[29] Wong SM, Jansen JFA, Zhang CE, Hoff EI, Staals J, van Oostenbrugge RJ, Backes WH. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease[J]. Neurology, 2019, 92:e1669-1677.
[30] Blair GW, Doubal FN, Thrippleton MJ, Marshall I, Wardlaw JM. Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease:a systematic review[J]. J Cereb Blood Flow Metab, 2016, 36:833-841.
[31] Deplanque D, Lavallee PC, Labreuche J, Gongora-Rivera F, Jaramillo A, Brenner D, Abboud H, Klein IF, Touboul PJ, Vicaut E, Amarenco P; Lacunar-BICHAT Investigators. Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients:a case-control study[J]. Int J Stroke, 2013, 8:413-421.
[32] Staszewski J, Skrobowska E, Piusińska-Macoch R, Brodacki B, St?pień A. Cerebral and extracerebral vasoreactivity in patients with different clinical manifestations of cerebral small-vessel disease:data from the significance of hemodynamic and hemostatic factors in the course of different manifestations of cerebral small-vessel disease study[J]. J Ultrasound Med, 2019, 38:975-987.
[33] Blair GW, Thrippleton MJ, Shi Y, Hamilton I, Stringer M, Chappell F, Dickie DA, Andrews P, Marshall I, Doubal FN, Wardlaw JM. Intracranial hemodynamic relationships in patients with cerebral small vessel disease[J]. Neurology, 2020, 94:e2258-2269.
[34] Fu JH, Lu CZ, Hong Z, Dong Q, Ding D, Wong KS. Relationship between cerebral vasomotor reactivity and white matter lesions in elderly subjects without large artery occlusive disease[J]. J Neuroimaging, 2006, 16:120-125.
[35] Kozera GM, Dubaniewicz M, Zdrojewski T, Madej-Dmochowska A, Mielczarek M, Wojczal J, Chwojnicki K, Swierblewska E, Schminke U, Wyrzykowski B, Nyka WM; SOPKARD Study Group. Cerebral vasomotor reactivity and extent of white matter lesions in middle-aged men with arterial hypertension:a pilot study[J]. Am J Hypertens, 2010, 23:1198-1203.
[36] Sam K, Crawley AP, Conklin J, Poublanc J, Sobczyk O, Mandell DM, Venkatraghavan L, Duffin J, Fisher JA, Black SE, Mikulis DJ. Development of white matter hyperintensity is preceded by reduced cerebrovascular reactivity[J]. Ann Neurol, 2016, 80:277-285.
[37] Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, Breteler MM. Prevalence and risk factors of cerebral microbleeds:an update of the rotterdam scan study[J]. Stroke, 2010, 41(10 Suppl):103-106.
[38] Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years[J]. Neurology, 2007, 68:214-222.
[39] Blanco PJ, Müller LO, Spence JD. Blood pressure gradients in cerebral arteries:a clue to pathogenesis of cerebral small vessel disease[J]. Stroke Vasc Neurol, 2017, 2:108-117.
[40] Spence JD. Blood pressure gradients in the brain:their importance to understanding pathogenesis of cerebral small vessel disease[J]. Brain Sci, 2019, 9:21.
[41] Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease:past, present, and future[J]. Annu Rev Pathol, 2018, 13:379-394.
[42] Mestre H, Kostrikov S, Mehta RI, Nedergaard M. Perivascular spaces, glymphatic dysfunction, and small vessel disease[J]. Clin Sci (Lond), 2017, 131:2257-2274.
[43] Brown R, Benveniste H, Black SE, Charpak S, Dichgans M, Joutel A, Nedergaard M, Smith KJ, Zlokovic BV, Wardlaw JM. Understanding the role of the perivascular space in cerebral small vessel disease[J]. Cardiovasc Res, 2018, 114:1462-1473.
[44] Xue Y, Liu N, Zhang M, Ren X, Tang J, Fu J. Concomitant enlargement of perivascular spaces and decrease in glymphatic transport in an animal model of cerebral small vessel disease[J]. Brain Res Bull, 2020, 161:78-83.
[45] Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, Xie L, Kang H, Xu Q, Liew JA, Plog BA, Ding F, Deane R, Nedergaard M. Impairment of paravascular clearance pathways in the aging brain[J]. Ann Neurol, 2014, 76:845-861.
[46] Liu Q, Yan L, Huang M, Zeng H, Satyanarayanan SK, Shi Z, Chen D, Lu JH, Pei Z, Yao X, Su H. Experimental alcoholism primes structural and functional impairment of the glymphatic pathway[J]. Brain Behav Immun, 2020, 85:106-119.
[47] Zhou Y, Cai J, Zhang W, Gong X, Yan S, Zhang K, Luo Z, Sun J, Jiang Q, Lou M. Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human[J]. Ann Neurol, 2020, 87:357-369.
[48] Riba-Llena I, Jiménez-Balado J, Castañé X, Girona A, López-Rueda A, Mundet X, Jarca CI, Álvarez-Sabin J, Montaner J, Delgado P. Arterial stiffness is associated with basal ganglia enlarged perivascular spaces and cerebral small vessel disease load[J]. Stroke, 2018, 49:1279-1281.
[49] Wardlaw JM, Benveniste H, Nedergaard M, Zlokovic BV, Mestre H, Lee H, Doubal FN, Brown R, Ramirez J, MacIntosh BJ, Tannenbaum A, Ballerini L, Rungta RL, Boido D, Sweeney M, Montagne A, Charpak S, Joutel A, Smith KJ, Black SE; Colleagues from the Fondation Leducq Transatlantic Network of Excellence on the Role of the Perivascular Space in Cerebral Small Vessel Disease. Perivascular spaces in the brain:anatomy, physiology and pathology[J]. Nat Rev Neurol, 2020, 16:137-153.
[50] Ding J, Sigurðsson S, Jónsson PV, Eiriksdottir G, Charidimou A, Lopez OL, van Buchem MA, Guðnason V, Launer LJ. Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia:the age, gene/environment susceptibility-reykjavik study[J]. JAMA Neurol, 2017, 74:1105-1112.